
Journal of the Chemical Society, Dalton Transactions p. 181 - 184 (2000)
Update date:2022-07-30
Topics:
Das, Anjan Kumar
Peng, Shie-Ming
Bhattacharya, Samaresh
Reaction of three oxime ligands (oximes of salicylaldehyde (HL1-O), 2-hydroxyacetophenone (HL2-O) and 2-hydroxynaphthylaldehyde (HL3-O); where H stands for the phenolic proton and O for the oxime oxygen) with [Ru(PPh3)3Cl2] in a 1:1 molar ratio brings about reduction of the oximes to imines and affords complexes of the form [Ru(PPh3)2(L)Cl2], where L stands for the deprotonated imine ligand which is coordinated as a N,O-donor forming a six-membered chelate ring. The structure of the [Ru(PPh3)2(L2)Cl2] complex has been solved by X-ray crystallography. The coordination sphere around ruthenium is composed of NOP2Cl2 with the two PPh3 ligands in mutually trans and the two chlorides in mutually cis positions. The [Ru(PPh3)2(L)Cl2] complexes are one-electron paramagnetic (low-spin d5, S= 1/2) and show rhombic EPR spectra in 1:1 dichloromethane-toluene solution at 77 K. In dichloromethane solution the [Ru(PPh3)2(L)Cl2] complexes show several intense LMCT transitions in the visible region, together with a weak ligand field transition near 1700 nm. Cyclic voltammetry on the [Ru(PPh3)2(L)Cl2] complexes shows a ruthenium(III)-ruthenium(II) reduction near -0.4 V vs. SCE and a ruthenium(III)-ruthenium(IV) oxidation in the range 0.88-1.15 V vs. SCE. The Royal Society of Chemistry 2000.
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu,China
QINGDAO NEW FLOURISH INTERNATIOANAL TRADE CO., LTD.
Contact:+86 532 80861829
Address:No. 1, Yinchuan East Road, 266061, Qingdao, China
Lonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Doi:10.1016/0022-328X(89)80098-1
(1989)Doi:10.1134/S107036321404015X
()Doi:10.1016/j.jfluchem.2010.11.003
(2011)Doi:10.1039/c6cc08797c
(2017)Doi:10.1021/ja010199v
(2001)Doi:10.1002/hlca.19890720723
(1989)